Hemgenix is a gene therapy that reduces the rate of abnormal bleeding in people with hemophilia B.
The post Sagard Healthcare, HCRx to acquire royalty interest in Hemgenix appeared first on PE Hub.
Source: https://www.pehub.com/sagard-healthcare-healthcare-royalty-to-buy-royalty-interest-in-hemgenix/
Powered by WPeMatico
Comments are closed.